Contract 75D30121P10145
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · December 3, 2020
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on December 3, 2020 for $10,000 of work in pharmaceutical preparation manufacturing. Performance is in Wilmington, DE. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 30, 2024. If all options are exercised, the contract could reach $50,000.
Contract details
- PIID
- 75D30121P10145
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Support- Professional: Other
- Place of performance
- Wilmington, DE
- First action
- December 3, 2020
- Latest action
- March 30, 2024
Description
VACCINE SATORAGE AND ROTATION
Modification timeline
-
March 30, 2024Mod P00003$0
-
April 14, 2021Mod P00001$0
-
December 3, 2020Base award$9.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121P10145?
Contract 75D30121P10145 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on December 3, 2020 for $10,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75D30121P10145?
Astrazeneca Pharmaceuticals Lp won contract 75D30121P10145 from Department Of Health And Human Services.
How much is contract 75D30121P10145 worth?
Contract 75D30121P10145 has obligated $10,000 to date, with a total potential value of $50,000 if all options are exercised.